0.25 ml Wegovy: the volume versus the dose, explained

The biggest misconception: 0.25 ml and 0.25 mg are not the same thing

Most people who land on this query have seen both numbers and assumed they must be equivalent. They're not. Wegovy is a solution (semaglutide dissolved in a clear liquid) and like any injectable medicine, it comes in a set volume. Each dose from a Wegovy pen is delivered in approximately 0.25 ml of fluid. The milligrams refer to how much active drug is packed into that volume, and that figure changes as you move through the dosing schedule.

At the start of treatment, 0.25 ml contains 0.25 mg of semaglutide. At a later step in the same volume, the concentration is higher. The barrel of the pen, the syringe markings, or the 0.5 ml graduation you might see on a multi-dose device are measuring fluid volume. The dose card your prescriber gives you, and the box itself, state the therapeutic dose in milligrams. If the volume stays the same but the milligrams go up, that's a more concentrated formulation, a different pen. The relationship between mg and ml in Wegovy pens is worth reading in full if you're still unsure how the two figures map onto each other.

This distinction matters practically. If you're reading the barrel and expecting to see 0.25 and matching it to your dose card, you may be looking at the wrong scale. Always go by what your prescriber and the Patient Information Leaflet tell you, not the volume markings in isolation.

What 0.25 mg actually does, and why it looks underwhelming

The 0.25 mg dose exists for one reason: to give your body time to get used to semaglutide before the therapeutic work begins. GLP-1 receptor agonists slow gastric emptying and act on appetite centres in the brain; starting too high causes the nausea, vomiting and digestive discomfort that lead people to stop treatment early. The NHS patient-level guidance on semaglutide explains this directly, framing the starting dose as a tolerability measure rather than a weight-management intervention in its own right.

Most people spend four weeks at 0.25 mg, then move up. The step from 0.25 mg to 0.5 mg is the first real therapeutic threshold. If you want to understand what that transition involves, the move from 0.25 to 0.5 mg is covered separately. The full schedule (from 0.25 mg through to the 2.4 mg maintenance dose, and now the 7.2 mg option approved by the MHRA in April 2026) is laid out on the Wegovy dose overview.

The practical upshot: if you're in your first four weeks and feel the medicine isn't doing much, that's by design. The starter phase is doing exactly what it should. Weight loss is not the job of the 0.25 mg step.

What arrives (and how to use the first pen

When a Wegovy prescription is dispensed through a regulated UK pharmacy, the pen arrives in plain, unbranded packaging via tracked DPD delivery) you get a notification on your phone with a one-hour window, which most people find less stressful than a surprise knock at the door. The pen itself is a pre-filled, pre-set device; there's no drawing up of liquid, no measuring of 0.25 ml, and no calculation required on your part. You click and inject at the thigh, abdomen, or upper arm, rotating the site each week. The guide to using the Wegovy pen covers technique, site rotation and what to expect on the day.

Storage matters: the pen should be kept refrigerated at 2–8°C. For the exact window during which an in-use pen may be kept at room temperature, check the Patient Information Leaflet in the box, that's the authoritative source, and the figure is one the prescriber and leaflet should confirm rather than any content page. The NHS semaglutide page gives patient-level guidance on storage and what to do if a dose is missed.

Titration is a clinical decision, not a personal one

A question our prescribers hear regularly: "Can I just stay on 0.25 mg to keep the side effects manageable?" The short answer is that the dose schedule exists because staying on the starter dose indefinitely means staying below the therapeutic range. Titration timing and pace are set by your prescriber based on how you're tolerating each step, not by a fixed calendar. If you're struggling with side effects, that's a conversation to have with your clinical team before the next dose, not a reason to self-adjust.

The titration guide explains the standard schedule and what the escalation is designed to achieve. For a broader look at what Wegovy is and how it sits alongside lifestyle changes, the Wegovy overview covers the full picture. If you're thinking about the cost of treatment at each stage, the Wegovy pricing page sets out what's involved in private prescription treatment in the UK.

Wegovy is a prescription-only medicine. If you'd like to understand whether it might be suitable for you, a prescriber at our GPhC-registered pharmacy can review your consultation the same day it's submitted. Start your free consultation and a real clinician reads it, not an automated system.